Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment

RLH Handels; MA Joore; A Tran-Duy; A Wimo; CAG Wolfs; FRJ Verhey; Hans Severens

doi:10.1016/j.jalz.2015.02.009

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment

RLH Handels, MA Joore, A Tran-Duy, A Wimo, CAG Wolfs, FRJ Verhey, Hans Severens

Health Technology Assessment (HTA)

Research output: Contribution to journal › Article › Academic › peer-review

18 Citations (Scopus)

Original language	English
Pages (from-to)	896-905
Number of pages	10
Journal	Alzheimers & Dementia
Volume	11
Issue number	8
DOIs	https://doi.org/10.1016/j.jalz.2015.02.009
Publication status	Published - 2015

Research programs

EMC NIHES-05-63-02 Quality

Access to Document

10.1016/j.jalz.2015.02.009

http://hdl.handle.net/1765/78591

Cite this

@article{8367be4a51ee4c73a7fd5c42ca4a3f0f,

title = "Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment",

author = "RLH Handels and MA Joore and A Tran-Duy and A Wimo and CAG Wolfs and FRJ Verhey and Hans Severens",

year = "2015",

doi = "10.1016/j.jalz.2015.02.009",

language = "English",

volume = "11",

pages = "896--905",

journal = "Alzheimers & Dementia",

issn = "1552-5260",

publisher = "Elsevier Inc.",

number = "8",

}

Handels, RLH, Joore, MA, Tran-Duy, A, Wimo, A, Wolfs, CAG, Verhey, FRJ & Severens, H 2015, 'Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment', Alzheimers & Dementia, vol. 11, no. 8, pp. 896-905. https://doi.org/10.1016/j.jalz.2015.02.009

Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment. / Handels, RLH; Joore, MA; Tran-Duy, A et al.
In: Alzheimers & Dementia, Vol. 11, No. 8, 2015, p. 896-905.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment

AU - Handels, RLH

AU - Joore, MA

AU - Tran-Duy, A

AU - Wimo, A

AU - Wolfs, CAG

AU - Verhey, FRJ

AU - Severens, Hans

PY - 2015

Y1 - 2015

U2 - 10.1016/j.jalz.2015.02.009

DO - 10.1016/j.jalz.2015.02.009

M3 - Article

C2 - 26071009

SN - 1552-5260

VL - 11

SP - 896

EP - 905

JO - Alzheimers & Dementia

JF - Alzheimers & Dementia

IS - 8

ER -